Drugs

Heterocyclic compounds with nitrogen hetero-atom(s) only: > Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: > Other: > Other: > Drugs

Duty Rate (from China)

28.7%
MFN Base Rate3.7%

Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)

Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Total Effective Rate28.7%

Products classified under HTS 2933.29.45.00

Metronidazole USP

Metronidazole is a synthetic nitroimidazole derivative classified as a drug under HTS 2933.29.4500 due to its unfused imidazole ring structure and primary use as an antibiotic. It treats anaerobic bacterial infections, protozoal infections like trichomoniasis, and certain gastrointestinal conditions.

Clotrimazole API

Clotrimazole is an imidazole antifungal agent used in pharmaceutical formulations under HTS 2933.29.4500 for its unfused imidazole ring. It inhibits ergosterol synthesis in fungal cell membranes, treating conditions like athlete's foot and yeast infections.

Econazole Nitrate USP

Econazole nitrate, a broad-spectrum imidazole antifungal drug, falls under HTS 2933.29.4500 due to its characteristic unfused imidazole ring structure. Used primarily in dermatological treatments for fungal infections of skin and nails.

Miconazole Nitrate BP

Miconazole nitrate, an imidazole-class antifungal drug under HTS 2933.29.4500, features an unfused imidazole ring essential for its ergosterol biosynthesis inhibition. Widely used in oral, topical, and vaginal antifungal treatments.

Ketoconazole USP

Ketoconazole, a synthetic imidazole antifungal drug classified under HTS 2933.29.4500, contains an unfused imidazole ring critical to its mechanism. Used systemically for serious fungal infections and topically for dandruff/seborrheic dermatitis.

Tioconazole API

Tioconazole, a 1-substituted imidazole antifungal under HTS 2933.29.4500, targets vaginal candidiasis through ergosterol binding. Its unfused imidazole ring defines its Chapter 29 chemical classification as a pharmaceutical drug substance.

Omoconazole Pharmaceutical Reference Standard

Omoconazole, a development-stage imidazole antifungal drug substance under HTS 2933.29.4500, features the unfused imidazole ring characteristic of this tariff provision. Used in clinical trials and analytical reference standards.

Butoconazole Nitrate USP

Butoconazole nitrate, an imidazole antifungal specifically for vulvovaginal candidiasis, classified under HTS 2933.29.4500 for its unfused imidazole ring structure. Provides single-dose treatment efficacy through prolonged vaginal retention.

Fenticonazole Nitrate

Fenticonazole nitrate, a broad-spectrum imidazole antifungal drug under HTS 2933.29.4500, contains the defining unfused imidazole ring. Effective against dermatophytes, yeasts, and Gram-positive bacteria in topical formulations.

Isoconazole Nitrate

Isoconazole nitrate, an imidazole derivative antifungal drug under HTS 2933.29.4500 featuring unfused imidazole ring, used for superficial mycoses. Combines antifungal and antibacterial activity for mixed skin infections.